Patents/Assignees

MYRIAD INTERNATIONAL GmbH

2 patents in portfolio

US12180551utility2024
Method of Using Biomarkers and Clinical Variables for Predicting Chemotherapy Benefit
0 cites
US11913078utility2024
Method for Breast Cancer Recurrence Prediction Under Endocrine Treatment
0 cites